FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

HESTERBIO

2,420
-0.8 (-0.03%)
Updated 03:28 23/07 IST

HESTERBIO Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for HESTERBIO
Disclaimer
0% Bullish
0% Bearish

HESTERBIO Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See HESTERBIO Share Price Targets >>

HESTERBIO Ratings

Long term HESTERBIO rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live HESTERBIO message board: Is HESTERBIO buy or sell? Should I buy HESTERBIO shares? Why are HESTERBIO shares falling? Should I invest in HESTERBIO stock?

  1. Home
  2. HESTERBIO Forum

HESTERBIO Share Price Discussion

N
Reputation: 15,563 • Today 3:11 AM
Only marginal difference in purchase price of Covishield, Covaxin for Centre: MoS Health
In fact, the Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries as recommended by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).
The Economic Times
Like
Reply
R
Reputation: 56 • Jun 15 3:33 AM

Type
Buy
Instrument
HESTERBIO
Entry Price
₹2,660
Price@Trade
₹2,641.15
Target Price
₹26,870
Stop Price
₹2,550
Valid Till
Jun 22, 2021 3:20 AM
Margin
₹266,000 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹2,550
Net P&L
-₹11,000 (-4.14%)

Like
Reply (9)
swap_vert
Trade
See all replies
Rokzzz @rokzzz
Jun 15 11:44 AM

After 20 th of this month, we could see the big move becoze of vaccine approval (Bharath biotech)
TrackerBot @trackerbot
Jun 18 3:23 AM

Update
Stoploss Hit
Exit Price
₹2,550
Rokzzz @rokzzz
Jun 22 9:03 AM

Today 10%up
S
Reputation: 0 • Jun 14 8:52 AM
Like
Reply
N
Reputation: 15,563 • Jun 9 5:11 AM
Hold Hester Biosciences, target price Rs 2870: ICICI Direct
Hester Biosciences Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 2319.82 Crore) operating in Agriculture/Horticulture/Livestock sector.
The Economic Times
Like
Reply
N
Reputation: 15,563 • Jun 8 8:36 AM
Hester Biosciences Q4 results: Profit jumps over two folds to Rs 10 cr
Consolidated revenue from operations stood at Rs 64.17 crore in the quarter under review. It was Rs 43.62 crore in the same period a year ago.
The Economic Times
Like
Reply
V
Reputation: 16,856 • Jun 7 1:36 AM

COMPANY NAME RESULT DATE
#AMANITRA - 08 Jun 2021
#ASWTR - 08 Jun 2021
#BELLACASA - 08 Jun 2021
#BHAGYAPROP - 08 Jun 2021
#BHARTIA - 08 Jun 2021
#CHOWGULSTM - 08 Jun 2021
#CISTRO - 08 Jun 2021
#DYNMICR - 08 Jun 2021
#ENGINERSIN - 08 Jun 2021
#ESSARSHPNG - 08 Jun 2021
#GA...
Read more...
1
Reply
N
Reputation: 15,563 • May 28 4:36 AM
Hester Biosciences jumps as company inks Covaxin pact
The scrip jumped 14 per cent to Rs 3,099 in early deals, but gave up some of those gains to trade at Rs 2,914.75 at 11:00 am.
The Economic Times
Like
Reply
N
Reputation: 15,563 • May 27 4:01 AM
Pact signed between Bharat Biotech, Gujarat Covid Vaccine Consortium: Hester Biosciences
GCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies Pvt Ltd, Hester Biosciences said in a regulatory filing.
The Economic Times
Like
Reply
N
Reputation: 15,563 • May 17 3:51 AM
Stock market update: 77 stocks hit 52-week highs on NSE
Overall, 35 shares were trading in green in Nifty50 index, while 14 were trading in red in the afternoon trade.
The Economic Times
Like
Reply
N
Reputation: 15,563 • May 17 3:31 AM
Hester Biosciences jumps 19% on Covaxin buzz
The pharma maker said it has tied up with the Gujarat government to explore production of COVID-19 vaccine through technology transfer from Bharat Biotech.
The Economic Times
Like
Reply

Type
Buy
Instrument
HESTERBIO
Entry Price
₹2,855.05
Price@Trade
₹2,855.05
Target Price
₹2,968.85
Stop Price
₹2,800
Valid Till
May 17, 2021 3:20 AM
Margin
₹285,505 approx for 100 Qty
Status
Exited
Exit Price
₹2,925
Net P&L
+₹6,995 (+2.45%)
Like
Reply (1)
swap_vert
Trade
See all replies
ICHIMOKU SANJIN @ichimoku
May 17 3:37 AM

Update
Exited
Exit Price
₹2,925
Net P&L
+₹6,995 (+2.45%)
N
Reputation: 15,563 • May 16 9:56 AM
Hester in talks with Bharat Biotech for production of COVID-19 vaccine via technology transfer
"A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine through technology from Bharat Biotech," Hester Biosciences CEO and MD Rajiv Gandhi said in a statement.
The Economic Times
Like
Reply
N
Reputation: 15,563 • May 15 2:26 AM
Gujarat govt in talks with Bharat Biotech to ramp up production of Covaxin: DBT
"Further, Gujarat Biotechnology Research Centre, Department of Science and Technology Govt of Gujarat along with Hester Biosciences and OmniBRx has also firmed up its discussions with Bharat Biotech to scale up the COVAXIN technology and to produce minimum 20 million doses per month. Technology transfer agreements have been finalised with all manufacturers,” the DBT said in a statement.
The Economic Times
Like
Reply

Type
Buy
Instrument
HESTERBIO
Entry Price
₹2,568
Price@Trade
₹2,568
Target Price
₹2,652.35
Stop Price
₹2,500
Valid Till
May 14, 2021 3:20 AM
Margin
₹205,440 approx for 80 Qty
Status
Stoploss Hit
Exit Price
₹2,500
Net P&L
-₹5,440 (-2.65%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
May 14 5:18 AM

Update
Stoploss Hit
Exit Price
₹2,500

HESTERBIO - chart - 2660496
#HESTERBIO MEDIUM TERM BUY MODE TGT 2698/3461 SL 1900(WEEKLY CLBS)
Like
Reply

Type
Buy
Instrument
HESTERBIO
Entry Price
₹2,170
Price@Trade
₹2,188.95
Target Price
₹2,200
Stop Price
₹2,155
Valid Till
Apr 8, 2021 3:20 AM
Margin
₹651,000 approx for 300 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
Faiz Ahmad @faizahmad
Apr 8 3:25 AM

Update
Exited before entry
Price @ Update
₹2,198.7

Type
Buy
Instrument
HESTERBIO
Entry Price
₹2,185
Price@Trade
₹2,188.15
Target Price
₹2,200
Stop Price
₹2,170
Valid Till
Apr 8, 2021 3:20 AM
Margin
₹655,500 approx for 300 Qty
Status
Target Achieved
Exit Price
₹2,200
Net P&L
+₹4,500 (+0.69%)
Like
Reply (4)
swap_vert
Trade
See all replies
Faiz Ahmad @faizahmad
Apr 8 3:12 AM

Update
Entry Price Modified
Price @ Update
₹2,185
Original Entry Price
₹2,194
New Entry Price
₹2,185
TrackerBot @trackerbot
Apr 8 3:12 AM

Update
Trade Entered
Entry Price
₹2,185
TrackerBot @trackerbot
Apr 8 3:12 AM

Update
Target Achieved
Exit Price
₹2,200
I
Reputation: 5,271 • Feb 8 3:10 AM
4
Reply

# Bird Flu is spreading fast. Companies gearing to fight poultry disease can be big beneficiaries. Buy, *Hester Bio*, *Rosari Biotech*, and *Titan Biotech*
# Bird flu scare and related diseases will drastically bring down the demand for poultry products. Sell and stay away from *...
Read more...
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • HESTERBIO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,364.92
    Enterprise Value1,394.97
    Price to Earnings45.5
    Price to Book Value9.41
    Return on Capital Employed0.24
    Return on Equity0.21
    Face Value10
    Dividend Yield0.01
  • HESTERBIO - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    31-Oct-18ICICIdirect.comBuy1,620
    25-Jan-18ICICIdirect.comBuy1,930
    30-Nov-17Karvy Stock BrokingBuy1,417
    29-Mar-17ICICIdirect.comBuy1,040
    HESTERBIO Brokerage Price Target
  • HESTERBIO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 23245024502394.052411.7
    Jul 222449.92449.92401.92420.8
    Jul 202435.3524502378.92385.75
    Jul 1924862511.4524222435.35
    Jul 1625242545.524752486.35
  • HESTERBIO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,523.03
    30 Day Moving Average₹2,546.25
    50 Day Moving Average₹2,619.25
    100 Day Moving Average₹2,305.28
    200 Day Moving Average₹2,021.82
  • HESTERBIO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue135123.220.1
    Operating Profit5040.940.22
    Profit Before Tax4332.940.31
    Net Income3024.840.21
  • HESTERBIO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds145119.740.21
    Total Liabilities6563.960.02
    Total Assets212183.70.15
  • HESTERBIO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity3127.10.14
    Cash from Investing Activity-26-15.490.68
    Cash from Financing Activity-5-5.14-0.03
    Net Cash FlowNA6.47-1
  • HESTERBIO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.140.14
    Return on Equity0.210.21
    Return on Capital Employed0.240.23
  • HESTERBIO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.5
    3 Year CAGR Growth in Operating Profit0.91
    3 Year CAGR Growth in EBIDTA0.72
    3 Year CAGR Growth in Net Income1.06
    3 Yr CAGR Growth - Diluted EPS1.03
  • HESTERBIO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.07
    5 Year CAGR Growth in Operating Profit1.23
    5 Year CAGR Growth in EBIDTA1.21
    5 Year CAGR Growth in Net Income2.1
    3 Yr CAGR Growth - Diluted EPS2.09
  • HESTERBIO - Recent News

    keyboard_arrow_down
    NewsBot
    Today 3:11 AM
    Only marginal difference in purchase price of Covishield, Covaxin for Centre: MoS Health
    The Economic Times
    NewsBot
    Jun 9 5:11 AM
    Hold Hester Biosciences, target price Rs 2870: ICICI Direct
    The Economic Times
    NewsBot
    Jun 8 8:36 AM
    Hester Biosciences Q4 results: Profit jumps over two folds to Rs 10 cr
    The Economic Times
    NewsBot
    May 28 4:36 AM
    Hester Biosciences jumps as company inks Covaxin pact
    The Economic Times
    NewsBot
    May 27 4:01 AM
    Pact signed between Bharat Biotech, Gujarat Covid Vaccine Consortium: Hester Biosciences
    The Economic Times
    NewsBot
    May 17 3:31 AM
    Hester Biosciences jumps 19% on Covaxin buzz
    The Economic Times
    NewsBot
    May 16 9:56 AM
    Hester in talks with Bharat Biotech for production of COVID-19 vaccine via technology transfer
    The Economic Times
    NewsBot
    May 15 2:26 AM
    Gujarat govt in talks with Bharat Biotech to ramp up production of Covaxin: DBT
    The Economic Times
    NewsBot
    Nov 4, 2020 6:43 AM
    Hold Hester Biosciences; target of Rs 1765: ICICI Direct
    Moneycontrol
    NewsBot
    Jun 30, 2020 6:08 AM
    Buy Hester Biosciences; target of Rs 1190: ICICI Direct
    Moneycontrol
  • HESTERBIO - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020